Macrogenics Stock Analysis

MacroGenics Stock Analysis Notes

About 94.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MacroGenics has Price/Earnings To Growth (PEG) ratio of 0.01. The entity recorded a loss per share of 1.57. The firm had not issued any dividends in recent years. MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. The company was incorporated in 2000 and is headquartered in Rockville, Maryland. Macrogenics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 427 people. To find out more about MacroGenics contact Scott MD at 301 251 5172 or learn more at https://www.macrogenics.com.

MacroGenics Investment Alerts

MacroGenics Upcoming and Recent Events

MacroGenics Largest EPS Surprises

View All Earnings Estimates

MacroGenics Environmental, Social, and Governance (ESG) Scores

MacroGenics Thematic Classifications

MacroGenics Stock Institutional Investors

Note, although MacroGenics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

MacroGenics Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 190.17 M.

MacroGenics Profitablity

The company has Profit Margin (PM) of (0.69) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.49 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.49.

Management Efficiency

MacroGenics has return on total asset (ROA) of (0.2215) % which means that it has lost $0.2215 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6217) %, meaning that it created substantial loss on money invested by shareholders. MacroGenics' management efficiency ratios could be used to measure how well MacroGenics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.04 in 2025. Return On Capital Employed is likely to rise to -0.76 in 2025. At this time, MacroGenics' Net Tangible Assets are fairly stable compared to the past year. Debt To Assets is likely to rise to 0.11 in 2025, whereas Total Assets are likely to drop slightly above 287.5 M in 2025.

Technical Drivers

As of the 30th of January, MacroGenics secures the Risk Adjusted Performance of (0.06), standard deviation of 3.93, and Mean Deviation of 3.02. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of MacroGenics, as well as the relationship between them.

MacroGenics Price Movement Analysis

MacroGenics Insider Trading Activities

MacroGenics Outstanding Bonds

MacroGenics Predictive Daily Indicators

MacroGenics Corporate Filings

MacroGenics Forecast Models

MacroGenics' time-series forecasting models are one of many MacroGenics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary MacroGenics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how MacroGenics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling MacroGenics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as MacroGenics. By using and applying MacroGenics Stock analysis, traders can create a robust methodology for identifying MacroGenics entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. MacroGenics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. MacroGenics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

MacroGenics stock analysis indicators help investors evaluate how MacroGenics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading MacroGenics shares will generate the highest return on investment. By understating and applying MacroGenics stock analysis, traders can identify MacroGenics position entry and exit signals to maximize returns.

When running MacroGenics' price analysis, check to measure MacroGenics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MacroGenics is operating at the current time. Most of MacroGenics' value examination focuses on studying past and present price action to predict the probability of MacroGenics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MacroGenics' price. Additionally, you may evaluate how the addition of MacroGenics to your portfolios can decrease your overall portfolio volatility.